ImpediMed Limited (ASX:IPD – Get Free Report) insider Christine Emmanuel-Donnelly bought 318,116 shares of the company’s stock in a transaction that occurred on Tuesday, March 4th. The stock was acquired at an average price of A$0.04 ($0.03) per share, with a total value of A$13,360.87 ($8,456.25).
ImpediMed Price Performance
The company has a market cap of $103.31 million, a P/E ratio of -5.27, a price-to-earnings-growth ratio of -102.50 and a beta of 2.86. The company has a quick ratio of 6.23, a current ratio of 6.33 and a debt-to-equity ratio of 2.81.
ImpediMed Company Profile
Further Reading
- Five stocks we like better than ImpediMed
- Top Stocks Investing in 5G Technology
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- How to Invest in the Best Canadian Stocks
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- 3 Small Caps With Big Return Potential
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for ImpediMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImpediMed and related companies with MarketBeat.com's FREE daily email newsletter.